This emerging new market for biotechnology-based ingredients for the health and beauty aid industries has an estimated market potential of $500 million to $1.0 billion dollar market over the next five to ten years.

In Asian countries, enzymes have been used for years as digestive aids. The use of enzymes for digesting roughage and as digestive aids for people with lactose intolerance was also introduced to North America and the world markets in the last decade. Many enzymes such as dextranase possess antimicrobial properties, leading to their use in products such as chewing gums, and in toothpaste as an anti-cavity agent and to reduce dental plaque accumulation. Catalase enzymes are used in contact lens cleaning solutions to remove residual hydrogen peroxide and other debris harmful to the eyes. The enzyme superoxide dismutase is already used in many eye care products.

These enzyme products represent just a few of many new products in the R&D pipeline, waiting to be launched to improve human health. The industry has recognized the health-enhancing potential of enzymes, resulting in campaigns to screen plants, marine animals and land animals to find sources of new health and beauty aid products and ingredients.

Work is underway at many companies to use proteases, lipases, amylases and other classes of enzymes for skin, hair and oral care products. In fact, the first new enzyme products for treating wrinkles, skin softening, dead skin removal, mouth wash, tooth whitening, toothpaste, hair shampoo, hair coloring and hair washing use are expected to be launched within the next 3-5 years.

Dyadic believes that its integrated C1 technology platform will play a major role in delivering functionally superior new ingredients which deliver true therapeutic value to consumers when they use health and beauty aid products. These gentle, biological ingredients will replace harsh chemicals that are currently found in these products and used daily by consumers worldwide.

Dyadic welcomes collaboration with companies in the health and beauty aids industries to discover, develop and manufacture unique and exclusive products to satisfy the unmet needs of this large and attractive market segment. Dyadic depends on its business partners to help define product and ingredient targets where its powerful C1 discovery (More at gene discovery) and expression (More at gene expression) technology can be beneficially applied to create truly differentiated products of higher health and therapeutic value for consumers.